Mcnulty Korea Co., Ltd. (KOSDAQ:222980)
2,115.00
+15.00 (0.71%)
At close: Oct 2, 2026
Mcnulty Korea Revenue
Mcnulty Korea had revenue of 26.94B KRW in the quarter ending June 30, 2026, with 8.01% growth. This brings the company's revenue in the last twelve months to 97.26B, up 3.89% year-over-year. In the year 2025, Mcnulty Korea had annual revenue of 96.31B with 8.42% growth.
Revenue (ttm)
97.26B
Revenue Growth
+3.89%
P/S Ratio
0.23
Revenue / Employee
908.99M
Employees
107
Market Cap
22.67B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 96.31B | 7.48B | 8.42% |
| Dec 31, 2024 | 88.83B | 10.43B | 13.31% |
| Dec 31, 2023 | 78.40B | 8.19B | 11.66% |
| Dec 31, 2022 | 70.21B | 16.80B | 31.46% |
| Dec 31, 2021 | 53.41B | 4.35B | 8.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bio Port Korea | 77.97B |
| The Lamy | 63.54B |
| Seoul Pharma | 51.08B |
| Moatech | 46.55B |
| TOEBOX KOREA.Ltd. | 41.19B |
| SPECO | 33.12B |
| People & Technology Ms | 29.22B |
| PNC Technologies co., | 27.61B |